Evidence map›Paper›PMID 35181819›Full record

ArticleEuropean journal of clinical pharmacology2022

Fast clearance of anti-TNFα agents unrelated to antidrug antibodies: a case report.

Stefania Cheli, Valeria Cozzi, Dario Cattaneo, Lorenzo Norsa, Costantino De Giacomo, Emilio Clementi, Chiara Moretti

Abstract readCase ReportsLetter
PubMed Publisher
In one paragraph

Article in European journal of clinical pharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.5field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Stefania CheliUnit of Clinical Pharmacology, L. Sacco University Hospital, Milan, Italy. stefania.cheli@asst-fbf-sacco.it.ORCID 0000-0002-2837-5248
Valeria CozziUnit of Clinical Pharmacology, L. Sacco University Hospital, Milan, Italy.
Dario CattaneoUnit of Clinical Pharmacology, L. Sacco University Hospital, Milan, Italy.
Lorenzo NorsaPediatric Hepatology, Gastroenterology and Transplantation Unit, ASST Papa Giovanni XXIII, Bergamo, Italy.
Costantino De GiacomoPediatrics Division, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
Emilio ClementiUnit of Clinical Pharmacology, Dept Biomedical and Clinical Sciences, L. Sacco University Hospital, University of Milan, Milan, Italy.
Chiara MorettiPediatrics Division, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
Luigi Sacco Hospital · ITAzienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda · ITOspedale Papa Giovanni XXIII · ITUniversity of Milan · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antirheumatic AgentsAdalimumabEtanerceptHumansInfliximabTumor Necrosis Factor-alphaAdalimumabAntirheumatic AgentsEtanerceptInfliximabTumor Necrosis Factor-alpha

Identifiers

PMID35181819
OpenAlexW4213352981

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.